Pre-order Enquiry
Request Free Sample
Global Transdermal Scopolamine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21748699 | Publishing Date : 21-Sep-2022 | No. of pages : 109
Detailed TOC of Global Transdermal Scopolamine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Transdermal Scopolamine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Tablet Type
1.2.3 Syrups Type
1.2.4 Injections Type
1.2.5 Patch Type
1.2.6 Gel Type
1.3 Market Segment by Application
1.3.1 Global Transdermal Scopolamine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Narcotic Analgesia
1.3.3 Cough
1.3.4 Asthma
1.3.5 Motion Sickness
1.3.6 Parkinson's Disease
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Transdermal Scopolamine Market Size (2017-2028)
2.1.1 Global Transdermal Scopolamine Revenue (2017-2028)
2.1.2 Global Transdermal Scopolamine Sales (2017-2028)
2.2 Global Transdermal Scopolamine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Transdermal Scopolamine Sales by Regions (2017-2022)
2.2.2 Global Transdermal Scopolamine Revenue by Regions (2017-2022)
2.3 Global Transdermal Scopolamine Market Size Forecast by Region
2.3.1 Global Transdermal Scopolamine Sales Forecast by Region (2023-2028)
2.3.2 Global Transdermal Scopolamine Revenue Forecast by Region (2023-2028)
2.4 Global Top Transdermal Scopolamine Regions (Countries) Ranking by Market Size
2.5 Transdermal Scopolamine Market Dynamics
2.5.1 Transdermal Scopolamine Market Trends
2.5.2 Transdermal Scopolamine Market Drivers
2.5.3 Transdermal Scopolamine Market Challenges
2.5.4 Transdermal Scopolamine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Transdermal Scopolamine Manufacturers by Sales (2017-2022)
3.1.1 Global Transdermal Scopolamine Sales by Manufacturers (2017-2022)
3.1.2 Global Transdermal Scopolamine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Transdermal Scopolamine Sales in 2021
3.2 Global Top Manufacturers Transdermal Scopolamine by Revenue
3.2.1 Global Transdermal Scopolamine Revenue by Manufacturers (2017-2022)
3.2.2 Top Transdermal Scopolamine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Transdermal Scopolamine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Transdermal Scopolamine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2021)
3.4 Global Transdermal Scopolamine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Transdermal Scopolamine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Transdermal Scopolamine Market
3.7 Key Manufacturers Transdermal Scopolamine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Transdermal Scopolamine Market Size by Type
4.1 Global Transdermal Scopolamine Historic Market Review by Type (2017-2022)
4.1.1 Global Transdermal Scopolamine Sales Market Share by Type (2017-2022)
4.1.2 Global Transdermal Scopolamine Revenue Market Share by Type (2017-2022)
4.1.3 Transdermal Scopolamine Price by Type (2017-2022)
4.2 Global Transdermal Scopolamine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Transdermal Scopolamine Sales Forecast by Type (2023-2028)
4.2.2 Global Transdermal Scopolamine Revenue Forecast by Type (2023-2028)
4.2.3 Transdermal Scopolamine Price Forecast by Type (2023-2028)
5 Global Transdermal Scopolamine Market Size by Application
5.1 Global Transdermal Scopolamine Historic Market Review by Application (2017-2022)
5.1.1 Global Transdermal Scopolamine Sales Market Share by Application (2017-2022)
5.1.2 Global Transdermal Scopolamine Revenue Market Share by Application (2017-2022)
5.1.3 Transdermal Scopolamine Price by Application (2017-2022)
5.2 Global Transdermal Scopolamine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Transdermal Scopolamine Sales Forecast by Application (2023-2028)
5.2.2 Global Transdermal Scopolamine Revenue Forecast by Application (2023-2028)
5.2.3 Transdermal Scopolamine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transdermal Scopolamine Sales Breakdown by Company
6.1.1 North America Transdermal Scopolamine Sales by Company (2017-2022)
6.1.2 North America Transdermal Scopolamine Revenue by Company (2017-2022)
6.2 North America Transdermal Scopolamine Market Size by Type
6.2.1 North America Transdermal Scopolamine Sales by Type (2017-2028)
6.2.2 North America Transdermal Scopolamine Revenue by Type (2017-2028)
6.3 North America Transdermal Scopolamine Market Size by Application
6.3.1 North America Transdermal Scopolamine Sales by Application (2017-2028)
6.3.2 North America Transdermal Scopolamine Revenue by Application (2017-2028)
6.4 North America Transdermal Scopolamine Market Size by Country
6.4.1 North America Transdermal Scopolamine Sales by Country (2017-2028)
6.4.2 North America Transdermal Scopolamine Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Scopolamine Sales Breakdown by Company
7.1.1 Europe Transdermal Scopolamine Sales by Company (2017-2022)
7.1.2 Europe Transdermal Scopolamine Revenue by Company (2017-2022)
7.2 Europe Transdermal Scopolamine Market Size by Type
7.2.1 Europe Transdermal Scopolamine Sales by Type (2017-2028)
7.2.2 Europe Transdermal Scopolamine Revenue by Type (2017-2028)
7.3 Europe Transdermal Scopolamine Market Size by Application
7.3.1 Europe Transdermal Scopolamine Sales by Application (2017-2028)
7.3.2 Europe Transdermal Scopolamine Revenue by Application (2017-2028)
7.4 Europe Transdermal Scopolamine Market Size by Country
7.4.1 Europe Transdermal Scopolamine Sales by Country (2017-2028)
7.4.2 Europe Transdermal Scopolamine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transdermal Scopolamine Sales Breakdown by Company
8.1.1 Asia Pacific Transdermal Scopolamine Sales by Company (2017-2022)
8.1.2 Asia Pacific Transdermal Scopolamine Revenue by Company (2017-2022)
8.2 Asia Pacific Transdermal Scopolamine Market Size by Type
8.2.1 Asia Pacific Transdermal Scopolamine Sales by Type (2017-2028)
8.2.2 Asia Pacific Transdermal Scopolamine Revenue by Type (2017-2028)
8.3 Asia Pacific Transdermal Scopolamine Market Size by Application
8.3.1 Asia Pacific Transdermal Scopolamine Sales by Application (2017-2028)
8.3.2 Asia Pacific Transdermal Scopolamine Revenue by Application (2017-2028)
8.4 Asia Pacific Transdermal Scopolamine Market Size by Region
8.4.1 Asia Pacific Transdermal Scopolamine Sales by Region
8.4.2 Asia Pacific Transdermal Scopolamine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Transdermal Scopolamine Sales Breakdown by Company
9.1.1 Latin America Transdermal Scopolamine Sales by Company (2017-2022)
9.1.2 Latin America Transdermal Scopolamine Revenue by Company (2017-2022)
9.2 Latin America Transdermal Scopolamine Market Size by Type
9.2.1 Latin America Transdermal Scopolamine Sales by Type (2017-2028)
9.2.2 Latin America Transdermal Scopolamine Revenue by Type (2017-2028)
9.3 Latin America Transdermal Scopolamine Market Size by Application
9.3.1 Latin America Transdermal Scopolamine Sales by Application (2017-2028)
9.3.2 Latin America Transdermal Scopolamine Revenue by Application (2017-2028)
9.4 Latin America Transdermal Scopolamine Market Size by Country
9.4.1 Latin America Transdermal Scopolamine Sales by Country (2017-2028)
9.4.2 Latin America Transdermal Scopolamine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Scopolamine Sales Breakdown by Company
10.1.1 Middle East and Africa Transdermal Scopolamine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Transdermal Scopolamine Revenue by Company (2017-2022)
10.2 Middle East and Africa Transdermal Scopolamine Market Size by Type
10.2.1 Middle East and Africa Transdermal Scopolamine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Transdermal Scopolamine Revenue by Type (2017-2028)
10.3 Middle East and Africa Transdermal Scopolamine Market Size by Application
10.3.1 Middle East and Africa Transdermal Scopolamine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Transdermal Scopolamine Revenue by Application (2017-2028)
10.4 Middle East and Africa Transdermal Scopolamine Market Size by Country
10.4.1 Middle East and Africa Transdermal Scopolamine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Transdermal Scopolamine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Overview
11.1.3 Baxter International Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Baxter International Transdermal Scopolamine Products and Services
11.1.5 Baxter International Transdermal Scopolamine SWOT Analysis
11.1.6 Baxter International Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Transdermal Scopolamine Products and Services
11.2.5 GlaxoSmithKline Transdermal Scopolamine SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Novartis AG Transdermal Scopolamine Products and Services
11.3.5 Novartis AG Transdermal Scopolamine SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Perrigo Company
11.4.1 Perrigo Company Corporation Information
11.4.2 Perrigo Company Overview
11.4.3 Perrigo Company Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Perrigo Company Transdermal Scopolamine Products and Services
11.4.5 Perrigo Company Transdermal Scopolamine SWOT Analysis
11.4.6 Perrigo Company Recent Developments
11.5 Caleb Pharmaceuticals
11.5.1 Caleb Pharmaceuticals Corporation Information
11.5.2 Caleb Pharmaceuticals Overview
11.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Products and Services
11.5.5 Caleb Pharmaceuticals Transdermal Scopolamine SWOT Analysis
11.5.6 Caleb Pharmaceuticals Recent Developments
11.6 Myungmoon Pharma
11.6.1 Myungmoon Pharma Corporation Information
11.6.2 Myungmoon Pharma Overview
11.6.3 Myungmoon Pharma Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Myungmoon Pharma Transdermal Scopolamine Products and Services
11.6.5 Myungmoon Pharma Transdermal Scopolamine SWOT Analysis
11.6.6 Myungmoon Pharma Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Pfizer Transdermal Scopolamine Products and Services
11.7.5 Pfizer Transdermal Scopolamine SWOT Analysis
11.7.6 Pfizer Recent Developments
11.8 Nichi-Iko
11.8.1 Nichi-Iko Corporation Information
11.8.2 Nichi-Iko Overview
11.8.3 Nichi-Iko Transdermal Scopolamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Nichi-Iko Transdermal Scopolamine Products and Services
11.8.5 Nichi-Iko Transdermal Scopolamine SWOT Analysis
11.8.6 Nichi-Iko Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Transdermal Scopolamine Value Chain Analysis
12.2 Transdermal Scopolamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Scopolamine Production Mode & Process
12.4 Transdermal Scopolamine Sales and Marketing
12.4.1 Transdermal Scopolamine Sales Channels
12.4.2 Transdermal Scopolamine Distributors
12.5 Transdermal Scopolamine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Transdermal Scopolamine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Transdermal Scopolamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet Type
Table 3. Major Manufacturers of Syrups Type
Table 4. Major Manufacturers of Injections Type
Table 5. Major Manufacturers of Patch Type
Table 6. Major Manufacturers of Gel Type
Table 7. Global Transdermal Scopolamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Transdermal Scopolamine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Transdermal Scopolamine Sales by Region (2017-2022) & (K Units)
Table 10. Global Transdermal Scopolamine Sales Market Share by Region (2017-2022)
Table 11. Global Transdermal Scopolamine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Transdermal Scopolamine Revenue Market Share by Region (2017-2022)
Table 13. Global Transdermal Scopolamine Sales Forecast by Region (2023-2028) & (K Units)
Table 14. Global Transdermal Scopolamine Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Transdermal Scopolamine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Transdermal Scopolamine Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Transdermal Scopolamine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Transdermal Scopolamine Market Trends
Table 19. Transdermal Scopolamine Market Drivers
Table 20. Transdermal Scopolamine Market Challenges
Table 21. Transdermal Scopolamine Market Restraints
Table 22. Global Transdermal Scopolamine Sales by Manufacturers (2017-2022) & (K Units)
Table 23. Global Transdermal Scopolamine Sales Share by Manufacturers (2017-2022)
Table 24. Global Transdermal Scopolamine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Transdermal Scopolamine Manufacturers by Revenue (US$ Million) in 2021
Table 26. Transdermal Scopolamine Revenue Share by Manufacturers (2017-2022)
Table 27. Global Transdermal Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2021)
Table 29. Key Manufacturers Transdermal Scopolamine Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 30. Key Manufacturers Transdermal Scopolamine Plants/Factories Distribution
Table 31. Key Manufacturers Transdermal Scopolamine Area Served
Table 32. Date of Key Manufacturers Enter into Transdermal Scopolamine Market
Table 33. Key Manufacturers Transdermal Scopolamine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Transdermal Scopolamine Sales (K Units) by Type (2017-2022)
Table 36. Global Transdermal Scopolamine Sales Share by Type (2017-2022)
Table 37. Global Transdermal Scopolamine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Transdermal Scopolamine Price (K Units) by Type (2017-2022)
Table 39. Global Transdermal Scopolamine Sales (K Units) by Type (2023-2028)
Table 40. Global Transdermal Scopolamine Sales Share by Type (2023-2028)
Table 41. Global Transdermal Scopolamine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Transdermal Scopolamine Revenue Share by Type (2023-2028)
Table 43. Global Transdermal Scopolamine Price (K Units) by Type (2023-2028)
Table 44. Global Transdermal Scopolamine Sales (K Units) by Application (2017-2022)
Table 45. Global Transdermal Scopolamine Sales Share by Application (2017-2022)
Table 46. Global Transdermal Scopolamine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Transdermal Scopolamine Price (K Units) by Application (2017-2022)
Table 48. Global Transdermal Scopolamine Sales (K Units) by Application (2023-2028)
Table 49. Global Transdermal Scopolamine Sales Share by Application (2023-2028)
Table 50. Global Transdermal Scopolamine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Transdermal Scopolamine Revenue Share by Application (2023-2028)
Table 52. Global Transdermal Scopolamine Price (K Units) by Application (2023-2028)
Table 53. North America Transdermal Scopolamine Sales by Company (2017-2022) & (K Units)
Table 54. North America Transdermal Scopolamine Sales Market Share by Company (2017-2022)
Table 55. North America Transdermal Scopolamine Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Transdermal Scopolamine Revenue Market Share by Company (2017-2022)
Table 57. North America Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 58. North America Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 59. North America Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 62. North America Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 63. North America Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 66. North America Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 67. North America Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Transdermal Scopolamine Sales by Company (2017-2022) & (K Units)
Table 70. Europe Transdermal Scopolamine Sales Market Share by Company (2017-2022)
Table 71. Europe Transdermal Scopolamine Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Transdermal Scopolamine Revenue Market Share by Company (2017-2022)
Table 73. Europe Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 74. Europe Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 75. Europe Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 78. Europe Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 79. Europe Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 82. Europe Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 83. Europe Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Transdermal Scopolamine Sales by Company (2017-2022) & (K Units)
Table 86. Asia Pacific Transdermal Scopolamine Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Transdermal Scopolamine Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Transdermal Scopolamine Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 90. Asia Pacific Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 91. Asia Pacific Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 94. Asia Pacific Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 95. Asia Pacific Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Transdermal Scopolamine Sales by Region (2017-2022) & (K Units)
Table 98. Asia Pacific Transdermal Scopolamine Sales by Region (2023-2028) & (K Units)
Table 99. Asia Pacific Transdermal Scopolamine Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Transdermal Scopolamine Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Transdermal Scopolamine Sales by Company (2017-2022) & (K Units)
Table 102. Latin America Transdermal Scopolamine Sales Market Share by Company (2017-2022)
Table 103. Latin America Transdermal Scopolamine Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Transdermal Scopolamine Revenue Market Share by Company (2017-2022)
Table 105. Latin America Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 106. Latin America Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 107. Latin America Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 110. Latin America Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 111. Latin America Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 114. Latin America Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 115. Latin America Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Transdermal Scopolamine Sales by Company (2017-2022) & (K Units)
Table 118. Middle East and Africa Transdermal Scopolamine Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Transdermal Scopolamine Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Transdermal Scopolamine Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 122. Middle East and Africa Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 123. Middle East and Africa Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 126. Middle East and Africa Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 127. Middle East and Africa Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 130. Middle East and Africa Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 131. Middle East and Africa Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 133. Baxter International Corporation Information
Table 134. Baxter International Description and Overview
Table 135. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 136. Baxter International Transdermal Scopolamine Product and Services
Table 137. Baxter International Transdermal Scopolamine SWOT Analysis
Table 138. Baxter International Recent Developments
Table 139. GlaxoSmithKline Corporation Information
Table 140. GlaxoSmithKline Description and Overview
Table 141. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 142. GlaxoSmithKline Transdermal Scopolamine Product and Services
Table 143. GlaxoSmithKline Transdermal Scopolamine SWOT Analysis
Table 144. GlaxoSmithKline Recent Developments
Table 145. Novartis AG Corporation Information
Table 146. Novartis AG Description and Overview
Table 147. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 148. Novartis AG Transdermal Scopolamine Product and Services
Table 149. Novartis AG Transdermal Scopolamine SWOT Analysis
Table 150. Novartis AG Recent Developments
Table 151. Perrigo Company Corporation Information
Table 152. Perrigo Company Description and Overview
Table 153. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 154. Perrigo Company Transdermal Scopolamine Product and Services
Table 155. Perrigo Company Transdermal Scopolamine SWOT Analysis
Table 156. Perrigo Company Recent Developments
Table 157. Caleb Pharmaceuticals Corporation Information
Table 158. Caleb Pharmaceuticals Description and Overview
Table 159. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 160. Caleb Pharmaceuticals Transdermal Scopolamine Product and Services
Table 161. Caleb Pharmaceuticals Transdermal Scopolamine SWOT Analysis
Table 162. Caleb Pharmaceuticals Recent Developments
Table 163. Myungmoon Pharma Corporation Information
Table 164. Myungmoon Pharma Description and Overview
Table 165. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 166. Myungmoon Pharma Transdermal Scopolamine Product and Services
Table 167. Myungmoon Pharma Transdermal Scopolamine SWOT Analysis
Table 168. Myungmoon Pharma Recent Developments
Table 169. Pfizer Corporation Information
Table 170. Pfizer Description and Overview
Table 171. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 172. Pfizer Transdermal Scopolamine Product and Services
Table 173. Pfizer Transdermal Scopolamine SWOT Analysis
Table 174. Pfizer Recent Developments
Table 175. Nichi-Iko Corporation Information
Table 176. Nichi-Iko Description and Overview
Table 177. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 178. Nichi-Iko Transdermal Scopolamine Product and Services
Table 179. Nichi-Iko Transdermal Scopolamine SWOT Analysis
Table 180. Nichi-Iko Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Transdermal Scopolamine Distributors List
Table 184. Transdermal Scopolamine Customers List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Scopolamine Product Picture
Figure 2. Global Transdermal Scopolamine Sales Market Share by Type in 2021 & 2028
Figure 3. Tablet Type Product Picture
Figure 4. Syrups Type Product Picture
Figure 5. Injections Type Product Picture
Figure 6. Patch Type Product Picture
Figure 7. Gel Type Product Picture
Figure 8. Global Transdermal Scopolamine Sales Market Share by Application in 2021 & 2028
Figure 9. Narcotic Analgesia Use Case
Figure 10. Cough Use Case
Figure 11. Asthma Use Case
Figure 12. Motion Sickness Use Case
Figure 13. Parkinson's Disease Use Case
Figure 14. Others Use Case
Figure 15. Transdermal Scopolamine Report Years Considered
Figure 16. Global Transdermal Scopolamine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Transdermal Scopolamine Market Size 2017-2028 (US$ Million)
Figure 18. Global Transdermal Scopolamine Sales (2017-2022) & (K Units)
Figure 19. Global Transdermal Scopolamine Market Size Market Share by Region: 2021 VS 2028
Figure 20. Global Transdermal Scopolamine Sales Market Share by Region (2017-2022)
Figure 21. Global Transdermal Scopolamine Sales Market Share by Region in 2021
Figure 22. Global Transdermal Scopolamine Revenue Market Share by Region in 2017 VS 2021
Figure 23. Global Transdermal Scopolamine Sales Share by Manufacturers in 2021
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Scopolamine Sales in 2021
Figure 25. Transdermal Scopolamine Revenue Share by Manufacturers in 2021
Figure 26. Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 27. Global Transdermal Scopolamine Revenue Share by Type (2017-2022)
Figure 28. Global Transdermal Scopolamine Revenue Growth Rate by Type in 2017 & 2021
Figure 29. Global Transdermal Scopolamine Revenue Share by Application (2017-2022)
Figure 30. Global Transdermal Scopolamine Revenue Growth Rate by Application in 2017 & 2021
Figure 31. North America Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 32. North America Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 33. North America Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 34. North America Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 35. North America Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 36. North America Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 37. U.S. Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 38. Canada Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 39. Europe Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 40. Europe Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 41. Europe Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 42. Europe Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 43. Europe Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 44. Europe Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 45. Germany Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 46. France Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 47. U.K. Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 48. Italy Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 49. Russia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 50. Asia Pacific Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 51. Asia Pacific Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 52. Asia Pacific Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 53. Asia Pacific Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 54. Asia Pacific Transdermal Scopolamine Sales Share by Region (2017-2028)
Figure 55. Asia Pacific Transdermal Scopolamine Revenue Share by Region (2017-2028)
Figure 56. China Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 57. Japan Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 58. South Korea Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 59. India Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 60. Australia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 61. China Taiwan Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 62. Indonesia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 63. Thailand Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 64. Malaysia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 65. Latin America Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 66. Latin America Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 67. Latin America Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 68. Latin America Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 69. Latin America Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 70. Latin America Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 71. Mexico Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 72. Brazil Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 73. Argentina Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 74. Middle East and Africa Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 79. Middle East and Africa Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 80. Turkey Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 81. Saudi Arabia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 82. UAE Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 83. Transdermal Scopolamine Value Chain
Figure 84. Transdermal Scopolamine Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Keyplayers in Global Transdermal Scopolamine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Baxter InternationalGlaxoSmithKline
Novartis AG
Perrigo Company
Caleb Pharmaceuticals
Myungmoon Pharma
Pfizer
Nichi-Iko
Request Sample
Request Discount
